Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.785
-0.205 (-10.30%)
At close: Apr 1, 2025, 4:00 PM
1.850
+0.065 (3.64%)
After-hours: Apr 1, 2025, 7:31 PM EDT

Prime Medicine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
2283738171,609--
Upgrade
Market Cap Growth
-54.41%-54.41%-49.22%---
Upgrade
Enterprise Value
782386691,890--
Upgrade
Last Close Price
1.782.928.8618.58--
Upgrade
PS Ratio
70.97124.90----
Upgrade
PB Ratio
1.492.436.145.09--
Upgrade
P/TBV Ratio
2.432.436.145.09--
Upgrade
EV/Sales Ratio
26.2379.89----
Upgrade
Debt / Equity Ratio
0.270.270.100.090.040.52
Upgrade
Asset Turnover
0.010.01---0.16
Upgrade
Quick Ratio
5.025.022.1611.004.652.74
Upgrade
Current Ratio
5.585.582.5311.104.672.75
Upgrade
Return on Equity (ROE)
-136.88%-136.88%-88.19%-43.83%-121.13%-19.56%
Upgrade
Return on Assets (ROA)
-51.51%-51.51%-43.15%-22.00%-29.61%-1.84%
Upgrade
Return on Capital (ROIC)
-74.30%-74.30%-48.63%-24.48%-35.09%-2.22%
Upgrade
Earnings Yield
-85.96%-52.58%-24.25%-7.57%--
Upgrade
FCF Yield
-57.12%-34.94%-21.31%-9.19%--
Upgrade
Buyback Yield / Dilution
-30.37%-30.37%-168.41%-161.23%-391.47%-77.53%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q